RetiSpec
PrivateLast Round
Series A
Jul 26, 2024
Total Funding Raised
$17M
Company Overview
RetiSpec is a health tech company that provides a platform for the early detection of neurodegenerative diseases through a non-invasive eye exam.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RetiSpec Comparables
Compare RetiSpec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Optina Diagnostics | 91% | |
| NeuroVision Imaging | 87% | |
| Cognoptix | 78% | |
RetiSpec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 26, 2024 | ||||
| Grant | Jul 7, 2023 | ||||
| Grant | Apr 13, 2023 | ||||
| Grant | May 25, 2022 | ||||
| Seed | Feb 1, 2020 | ||||
Grant | Oct 8, 2019 |
RetiSpec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Brain Institute | Grant, Seed, Series A |
| Verge HealthTech Fund | Seed, Series A |
| Discovery Capital Funding | Seed, Series A |
| Davos Alzheimer's Collaborative | Grant |
| iGan Partners | Series A |
| Centre for Aging and Brain Health Innovation | Seed, Series A, Grant |
| Alzheimer's Drug Discovery Foundation | Grant, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2024
$10M round led by iGan Partners.
- Apr 13, 2023
Received grant funding from Centre for Aging and Brain Health Innovation.
RetiSpec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RetiSpec's valuation, stock price, and market status.